CASE REPORTS

A case of acute primary amoebic meningoencephalitis

  • ZHU Canmin ,
  • PENG Weijian ,
  • WANG Dili ,
  • ZHOU Huajing ,
  • JIN Qiangjian ,
  • CHANG Chang
Expand
  • Department of neurology, the first People's Hospital of Jiangxia District/Union Jiangnan Hospital, Wuhan 430025, Hubei, China

Received date: 2023-01-29

  Revised date: 2023-03-17

  Online published: 2023-09-06

Abstract

The 50-year-old male patient is a construction worker from Wuhan, Hubei. On August 3rd, 2022, he was administrated with oral antibiotics and antipyretic treatment at the fever clinic of the First People's Hospital/Union Medical College Jiangnan Hospital in Jiangxia District, Wuhan due to fever. However, his condition did not improve. The next day, the family discovered that the patient was mentally ill, restless, and talking nonsense, so the patient was transferred to the neurology department. The family reported that the patient swam in a lake near the construction site on July 29th, 2022. On August 3rd, he developed a fever with a maximum body temperature of 39.0 ℃, accompanied by pain in the neck and vomiting. Admission examination showed clear consciousness, mild delirium, unable to cooperate with the examination, positive bilateral Pap sign, stiffed neck with a gap of 4 fingers, and positive bilateral K sign. Blood routine examination shows that white blood cell count is 17.5 × 109/L with 86.5% neutrophils and procalcitonin 0.16 ng/ml. Lumbar puncture cerebrospinal fluid examination on August 5th showed a normal cerebrospinal pressure (145 mmH2O, 1 mmH2O = 9.779 Pa), an increase in white blood cell count (4 265.00 × 106/L), multinucleated cells were increased (88.00%), Pan's protein test was positive, the total protein increased (2 394.2 mg/L), glucose was decreased (0.15 mmol/L), chloride was normal (114.66 mmol/L), potassium wad decreased (2.75 mmol/L). The head CT scan showed lacunar infarction in the left basal ganglia area. The high-throughput genetic examination of pathogenic microorganisms in the cerebrospinal fluid revealed Naegleria fowleri, with a relative abundance of 98.76%. Based on the epidemiological history, clinical symptoms and laboratory examination results, the diagnosis of primary amoebic meningoencephalitis was made. Dehydration, intracranial pressure reduction, anti-infection, anti-epilepsy, and maintenance of water-electrolyte balance were administered with mannitol (125 ml/6 h), ceftriaxone sodium (2.0 g/12 h), amphotericin B (1 mg on August 6th, 2 mg on August 7th, 3 mg on August 8th, and 4 mg on August 9th) were administered. Although the patient managed to control the seizure after treatment, the condition worsened gradually and on August 9th, he developed a cerebral hernia and died.

Cite this article

ZHU Canmin , PENG Weijian , WANG Dili , ZHOU Huajing , JIN Qiangjian , CHANG Chang . A case of acute primary amoebic meningoencephalitis[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023 , 41(4) : 524 -526 . DOI: 10.12140/j.issn.1000-7423.2023.04.023

References

[1] Mungroo MR, Anwar A, Khan NA, et al. Brain-eating amoebae infection: challenges and opportunities in chemotherapy[J]. Mini Rev Med Chem, 2019, 19(12): 980-987.
[2] Ong TYY, Khan NA, Siddiqui R. Brain-eating amoebae: predilection sites in the brain and disease outcome[J]. J Clin Microbiol, 2017, 55(7): 1989-1997.
[3] Jahangeer M, Mahmood Z, Munir N, et al. Naegleria fowleri: sources of infection, pathophysiology, diagnosis, and management; a review[J]. Clin Exp Pharmacol Physiol, 2020, 47(2): 199-212.
[4] Geographic range of recreational water-associated primary amebic meningoencephalitis, United States, 1978—2018[J]. Pediatr Infect Dis J, 2021, 40(4): 358.
[5] Grace E, Asbill S, Virga K. Naegleria fowleri: pathogenesis, diagnosis, and treatment options[J]. Antimicrob Agents Chemother, 2015, 59(11): 6677-6681.
[6] Berger JR. Amebic infections of the central nervous system[J]. J Neurovirol, 2022, 28(4/5/6): 467-472.
[7] Capewell LG, Harris AM, Yoder JS, et al. Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937—2013[J]. J Pediatric Infect Dis Soc, 2015, 4(4): e68-e75.
[8] Wang Q, Li JM, Ji JK, et al. A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing[J]. BMC Infect Dis, 2018, 18(1): 349.
[9] Huang SQ, Liang XA, Han YL, et al. A pediatric case of primary amoebic meningoencephalitis due to Naegleria fowleri diagnosed by next-generation sequencing of cerebrospinal fluid and blood samples[J]. BMC Infect Dis, 2021, 21(1): 1251.
[10] Debnath A. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads[J]. Expert Rev Anti Infect Ther, 2021, 19(9): 1099-1106.
[11] Güémez A, García E. Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments[J]. Biomolecules, 2021, 11(9): 1320.
[12] ?cal Demir S, Besli GE, Bucak A, et al. Successful treatment of Acanthamoeba meningoencephalitis in an immunocompetent child[J]. J Trop Pediatr, 2021, 67(2): 102.
[13] Martínez DY, Bravo-Cossio F, Valdivia-Tapia MDC, et al. Successful treatment of primary amoebic meningoencephalitis using a novel therapeutic regimen including miltefosine and voriconazole[J]. Acta Parasitol, 2022, 67(3): 1421-1424.
[14] Harris GR, Karmarkar EN, Quenelle R, et al. Death from primary amebic meningoencephalitis after recreational water exposure during recent travel to India-Santa Clara County, California, 2020[J]. Open Forum Infect Dis, 2021, 8(8): 322.
[15] Malik MW, Awan UA, Ahmed H, et al. Environmental surveillance of Naegleria fowleri: a way forward for control of primary amoebic meningoencephalitis cases in Pakista[J]. Travel Med Infect Dis, 2022, 45: 102235.
Outlines

/

〈 〉